Literature DB >> 27023050

Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.

Moritz Wildgruber1, Claudia Lueg2, Sebastian Borgmeyer3, Ilham Karimov2, Ulrike Braun4, Marion Kiechle5, Reinhard Meier6, Michael Koehler7, Johannes Ettl5, Hermann Berger2.   

Abstract

PURPOSE: We aimed to analyse short and long-term complications of polyurethane (PU) versus silicone catheters used in totally implantable venous-access ports (TIVAPs) implanted at the forearm.
METHODS: Retrospective analysis of 698 consecutively implanted TIVAPs was performed. Primary end-points were defined as rates of major complications associated with either type of central venous port catheter. Technical success rate, device service interval as well as minor complications not requiring port explantation were defined as secondary end-points.
RESULTS: A total of 698 port devices were implanted in 681 patients, 396 equipped with a PU catheter, 302 with a silicone catheter. The technical success rate was 99.9% with no major periprocedural complications. During follow-up a total of 211 complications in 146 patients were observed (1.0/1000 catheter days), 183 occurred associated with PU catheters (1.8/100 catheter days), 28 (0.3/1000 catheter days) with silicone catheters (log rank test p < 0.0001). Catheter-related bloodstream infections as well as thrombotic complications occurred significantly more frequently with PU catheters, while silicone catheters exhibited a trend towards a higher rate of mechanical failure such as disconnection or catheter rupture. Major complications requiring explantation of the device occurred more frequently with PU-based catheters (10.6%) compared to silicone catheter carrying ports (4.6%, log rank test p < 0.001).
CONCLUSION: PU catheters are more susceptible to catheter-related infections and exhibit a higher thrombogenicity, compared to silicone catheters. Silicone catheters instead exhibit a trend towards decreased mechanical stability.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Central venous access port; Chemotherapy; Complication; Infection; Thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27023050     DOI: 10.1016/j.ejca.2016.02.011

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  13 in total

1.  Do bevacizumab solutions interact with silicone or polyurethane catheters during an infusion through implantable venous access ports?

Authors:  Nicolas Tokhadzé; Philip Chennell; Régis Cueff; Valérie Sautou
Journal:  J R Soc Interface       Date:  2019-09-25       Impact factor: 4.118

2.  A Readily Scalable, Clinically Demonstrated, Antibiofouling Zwitterionic Surface Treatment for Implantable Medical Devices.

Authors:  Brian McVerry; Alexandra Polasko; Ethan Rao; Reihaneh Haghniaz; Dayong Chen; Na He; Pia Ramos; Joel Hayashi; Paige Curson; Chueh-Yu Wu; Praveen Bandaru; Mackenzie Anderson; Brandon Bui; Aref Sayegh; Shaily Mahendra; Dino Di Carlo; Evgeniy Kreydin; Ali Khademhosseini; Amir Sheikhi; Richard B Kaner
Journal:  Adv Mater       Date:  2022-04-11       Impact factor: 32.086

3.  Increased risk of symptomatic upper-extremity venous thrombosis with multiple peripherally inserted central catheter insertions in pediatric patients.

Authors:  Ralph Gnannt; Nicolas Waespe; Michael Temple; Afsaneh Amirabadi; Kuan Liu; Leonardo R Brandão; Bairbre L Connolly
Journal:  Pediatr Radiol       Date:  2018-02-27

4.  Implantable port thrombosis in cancer patients: a monocentric experience.

Authors:  Manel Dridi; Nesrine Mejri; Soumaya Labidi; Mehdi Afrit; Houda El Benna; Khaoula Ben Miled; Hamouda Boussen
Journal:  Cancer Biol Med       Date:  2016-09       Impact factor: 4.248

5.  A new approach by optical coherence tomography for elucidating biofilm formation by emergent Candida species.

Authors:  Melyna Chaves Leite de Andrade; Marcos Andre Soares de Oliveira; Franz de Assis Graciano Dos Santos; Pamella de Brito Ximenes Vilela; Michellangelo Nunes da Silva; Danielle Patrícia Cerqueira Macêdo; Reginaldo Gonçalves de Lima Neto; Henrique Jonh Pereira Neves; Ildnay de Souza Lima Brandão; Guilherme Maranhão Chaves; Renato Evangelista de Araujo; Rejane Pereira Neves
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

6.  Potential efficacy of garlic lock therapy in combating biofilm and catheter-associated infections; experimental studies on an animal model with focus on toxicological aspects.

Authors:  Hala A Farrag; Alaa El-Dien M S Hosny; Asrar M Hawas; Soheir A A Hagras; Omneya M Helmy
Journal:  Saudi Pharm J       Date:  2019-05-15       Impact factor: 4.330

7.  Femoral placement of a totally implantable venous access port with spontaneous catheter fracture: case report.

Authors:  Tomohiro Kondo; Shigemi Matsumoto; Keitaro Doi; Motoo Nomura; Manabu Muto
Journal:  CVIR Endovasc       Date:  2020-01-06

8.  Human blood plasma factors affect the adhesion kinetics of Staphylococcus aureus to central venous catheters.

Authors:  Gubesh Gunaratnam; Christian Spengler; Simone Trautmann; Philipp Jung; Johannes Mischo; Ben Wieland; Carlos Metz; Sören L Becker; Matthias Hannig; Karin Jacobs; Markus Bischoff
Journal:  Sci Rep       Date:  2020-12-02       Impact factor: 4.379

9.  Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol.

Authors:  Barbara L LeVarge; Anica C Law; Blanche Murphy
Journal:  Pulm Circ       Date:  2018 Jan-Mar       Impact factor: 3.017

10. 

Authors:  Alexandre Faraco de Oliveira; Horácio de Oliveira
Journal:  J Vasc Bras       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.